Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Generering af repræsentativ biobank bestående af klinisk relevante Pseudomonas aeruginosa (P.a) isolater fra cystisk fibrose patienter til udvikling af multi-komponent vaccine | 2019 - 2020 | Innobooster
|
|
|
Generering af repræsentativ biobank bestående af klinisk relevante Pseudomonas aeruginosa (P.a) isolater fra cystisk fibrose patienter til udvikling af multi-komponent vaccine
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
299.268 Budget
906.875 Partners
Evaxion Biotech People
EVAXION BIOTECH A/S
Read more about the project
| |||
| GLØD -Bedre nætter | 2019 - 2020 | Innobooster
|
|
|
GLØD -Bedre nætter
Period
2019 - 2020
Region
Region Midtjylland Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
347.820 Budget
1.1 mill. Partners
GLØD IVS People
Glød IVS
Read more about the project
| |||
| HeatCath | 2019 - 2020 | Innobooster
|
|
|
HeatCath
Period
2019 - 2020
Region
Region Nordjylland Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
491.700 Budget
1.5 mill. Partners
Heathcath Aps People
Heathcath ApS
Read more about the project
| |||
| HEDIA device connectivity | 2019 - 2020 | Innobooster
|
|
|
HEDIA device connectivity
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
29.27 Invested
480.000 Budget
1.6 mill. Partners
Hedia People
Hedia ApS
Read more about the project
| |||
| High content screening platform for industrial enzyme engineering | 2019 - 2022 | Industrial Researcher
|
|
|
High content screening platform for industrial enzyme engineering
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
48.09 Invested
1.2 mill. Budget
2.6 mill. Partners
University of Copenhagen, NOVOZYMES A/S People
NOVOZYMES A/S
Read more about the project
| |||
| Hospital@Night H@N | 2019 - 2022 | Grand Solutions
|
|
|
Hospital@Night H@N
Period
2019 - 2022
Region
Region Midtjylland Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
67.51 Invested
19.3 mill. Budget
28.5 mill. Partners
Aarhus University, Systematic A/S, Aalborg Universitetshospital, Aarhus University Hospital People
SYSTEMATIC A/S
Read more about the project
| |||
| Human clinical proof-of-concept for a novel concept for treating atrial fibrillation (AF) | 2019 - 2020 | Innobooster
|
|
|
Human clinical proof-of-concept for a novel concept for treating atrial fibrillation (AF)
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
25.67 Invested
5.0 mill. Budget
19.3 mill. Partners
Acesion Pharma ApS People
ACESION PHARMA ApS
Read more about the project
| |||
| Human iPSC based in vitro and in vivo models to qualify how drug targets in inflammatory astrocytes and microglia affect neuronal pathology development | 2019 - 2022 | Industrial Researcher
|
|
|
Human iPSC based in vitro and in vivo models to qualify how drug targets in inflammatory astrocytes and microglia affect neuronal pathology development
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
41.94 Invested
1.2 mill. Budget
3.0 mill. Partners
H LUNDBECK A/S People
H LUNDBECK A/S
Read more about the project
| |||
| Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT | 2019 - 2022 | Grand Solutions
|
|
|
Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT
Period
2019 - 2022
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
63.12 Invested
7.1 mill. Budget
11.3 mill. Partners
Glycom A/S, Technical University of Denmark People
GLYCOM A/S
Read more about the project
| |||
| iBiocover-Bioteknologisk reduktion af metanudslip fra lossepladser | 2019 - 2020 | Innobooster
|
|
|
iBiocover-Bioteknologisk reduktion af metanudslip fra lossepladser
Period
2019 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
173.250 Budget
525.000 Partners
Danish Waste Solutions ApS People
DANISH WASTE SOLUTIONS ApS
Read more about the project
| |||
| Identification and validation of fibrosis targets in non-alcoholic steatohepatitis | 2019 - 2022 | Industrial Researcher
|
|
|
Identification and validation of fibrosis targets in non-alcoholic steatohepatitis
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
56.57 Invested
1.1 mill. Budget
1.9 mill. Partners
University of Copenhagen, Gubra People
Gubra
Read more about the project
| |||
| IF - InnoFounder - graduate - 2019 | 2019 - 2020 | Innofounder
|
|
|
IF - InnoFounder - graduate - 2019
Period
2019 - 2020
Region
Region Hovedstaden Program
Innofounder Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
215.000 Budget
215.000 Partners
Sonohaler ApS People
Sonohaler ApS
Read more about the project
| |||
| ImmPACT - Precision Activated Cell Therapy | 2019 - 2020 | Innoexplorer
|
|
|
ImmPACT - Precision Activated Cell Therapy
Period
2019 - 2020
Region
Region Hovedstaden Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
Danmarks Tekniske Universitet People
Danmarks Tekniske Universitet
Read more about the project
| |||
| Immune stealthing of bio-therapeutics | 2019 - 2021 | Industrial Researcher
|
|
|
Immune stealthing of bio-therapeutics
Period
2019 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
46.94 Invested
1.1 mill. Budget
2.3 mill. Partners
Technical University of Denmark, Immunitrack People
Immunitrack
Read more about the project
| |||
| IMPROVE Intervention Trial 2: Implementing non-invasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer IMPROVE IT2 | 2019 - 2024 | Grand Solutions
|
|
|
IMPROVE Intervention Trial 2: Implementing non-invasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer IMPROVE IT2
Period
2019 - 2024
Region
Region Midtjylland Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
74.33 Invested
12.6 mill. Budget
16.9 mill. Partners
Aarhus University Hospital, Regionshospitalet Randers, Genodesk Aps, Aarhus University Hospital, University of Southern Denmark People
Region Midtjylland
Read more about the project
| |||